Replies to post #6461 on GTC Biotherapeutics (fka GTCB)

[keitern]

It will expand and hopefuly improve a lot. When I say improve I think in terms of executing the studies for each candidate, in terms of safety and managing risk and so on.

[anotherbiotechguy]

Of course it will, and they have talented people. With that in mind, think of the shear number of talented people working throughout the biotech industry trying to improve other more widespread methods such as cell culture. I believe the odds of signifigant advance either through hardware or cell design are in their favor.